Cardiovascular and Interventional Radiological Society of Europe Commentary on the Treatment of Chronic Cerebrospinal Venous Insufficiency

por Reekers, J. A., Lee, M. J., Belli, A. M., Barkhof, F.
Publicado 2010

Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks()

por Popescu, V., Ran, N.C.G., Barkhof, F., Chard, D.T., Wheeler-Kingshott, C.A., Vrenken, H.
Publicado 2014

The pedunculopontine nucleus is related to visual hallucinations in Parkinson’s disease: preliminary results of a voxel-based morphometry study

por Janzen, J., van ‘t Ent, D., Lemstra, A. W., Berendse, H. W., Barkhof, F., Foncke, E. M. J.
Publicado 2011

Dementia imaging in clinical practice: a European-wide survey of 193 centres and conclusions by the ESNR working group

por Vernooij, M. W., Pizzini, F. B., Schmidt, R., Smits, M., Yousry, T. A., Bargallo, N., Frisoni, G. B., Haller, S., Barkhof, F.
Publicado 2019

Non-linear registration improves statistical power to detect hippocampal atrophy in aging and dementia

por Bartel, F., Visser, M., de Ruiter, M., Belderbos, J., Barkhof, F., Vrenken, H., de Munck, J.C., van Herk, M.
Publicado 2019

Comparing lesion segmentation methods in multiple sclerosis: Input from one manually delineated subject is sufficient for accurate lesion segmentation

por Weeda, M.M., Brouwer, I., de Vos, M.L., de Vries, M.S., Barkhof, F., Pouwels, P.J.W., Vrenken, H.
Publicado 2019

Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space study()

por Van der Meer, M.L., Tewarie, P., Schoonheim, M.M., Douw, L., Barkhof, F., Polman, C.H., Stam, C.J., Hillebrand, A.
Publicado 2013

Real-world keystroke dynamics are a potentially valid biomarker for clinical disability in multiple sclerosis

por Lam, KH, Meijer, KA, Loonstra, FC, Coerver, EME, Twose, J, Redeman, E, Moraal, B, Barkhof, F, de Groot, V, Uitdehaag, BMJ, Killestein, J
Publicado 2020

Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients

por van Lierop, ZYGJ, Toorop, AA, Coerver, EME, Willemse, EAJ, Strijbis, EMM, Kalkers, NF, Moraal, B, Barkhof, F, Teunissen, CE, Killestein, J, van Kempen, ZLE
Publicado 2021

FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosis

por Goodkin, O., Prados, F., Vos, S.B., Pemberton, H., Collorone, S., Hagens, M.H.J., Cardoso, M.J., Yousry, T.A., Thornton, J.S., Sudre, C.H., Barkhof, F.
Publicado 2020

Diffusion tensor imaging in type 1 diabetes: decreased white matter integrity relates to cognitive functions

por van Duinkerken, E., Schoonheim, M. M., IJzerman, R. G., Klein, M., Ryan, C. M., Moll, A. C., Snoek, F. J., Barkhof, F., Diamant, M., Pouwels, P. J. W.
Publicado 2012

Feasibility of detecting atrophy relevant for disability and cognition in multiple sclerosis using 3D-FLAIR

por Noteboom, Samantha, van Nederpelt, D. R., Bajrami, A., Moraal, B., Caan, M. W. A., Barkhof, F., Calabrese, M., Vrenken, H., Strijbis, E. M. M., Steenwijk, M. D., Schoonheim, M. M.
Publicado 2023

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT

por Edan, G, Kappos, L, Montalbán, X, Polman, C H, Freedman, M S, Hartung, H-P, Miller, D, Barkhof, F, Herrmann, J, Lanius, V, Stemper, B, Pohl, C, Sandbrink, R, Pleimes, D
Publicado 2014

T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis

por Bodini, B, Battaglini, M, De Stefano, N, Khaleeli, Z, Barkhof, F, Chard, D, Filippi, M, Montalban, X, Polman, C, Rovaris, M, Rovira, A, Samson, R, Miller, D, Thompson, A, Ciccarelli, O
Publicado 2010

Predicting clinical progression in multiple sclerosis after 6 and 12 years

por Dekker, I., Eijlers, A. J. C., Popescu, V., Balk, L. J., Vrenken, H., Wattjes, M. P., Uitdehaag, B. M. J., Killestein, J., Geurts, J. J. G., Barkhof, F., Schoonheim, M. M.
Publicado 2019

Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis

por van den Elskamp, I. J., Boden, B., Dattola, V., Knol, D. L., Filippi, M., Kappos, L., Fazekas, F., Wagner, K., Pohl, C., Sandbrink, R., Polman, C. H., Uitdehaag, B. M. J., Barkhof, F.
Publicado 2010

Bullseye's representation of cerebral white matter hyperintensities

por Sudre, C.H., Gomez Anson, B., Davagnanam, I., Schmitt, A., Mendelson, A.F., Prados, F., Smith, L., Atkinson, D., Hughes, A.D., Chaturvedi, N., Cardoso, M.J., Barkhof, F., Jaeger, H.R., Ourselin, S.
Publicado 2018

Validation of mean upper cervical cord area (MUCCA) measurement techniques in multiple sclerosis (MS): High reproducibility and robustness to lesions, but large software and scanne...

por Weeda, M.M., Middelkoop, S.M., Steenwijk, M.D., Daams, M., Amiri, H., Brouwer, I., Killestein, J., Uitdehaag, B.M.J., Dekker, I., Lukas, C., Bellenberg, B., Barkhof, F., Pouwels, P.J.W., Vrenken, H.
Publicado 2019

MRI CRITERIA FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS: MAGNIMS CONSENSUS GUIDELINES

por Filippi, M., Rocca, M.A., Ciccarelli, O., De Stefano, N., Evangelou, N., Kappos, L., Rovira, A., Sastre-Garriga, J., Tintorè, M., Frederiksen, J.L., Gasperini, C., Palace, J., Reich, D.S., Banwell, B., Montalban, X., Barkhof, F.
Publicado 2016

Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a...

por Vrenken, H., Battaglini, M., de Vos, M. L., Nagtegaal, G. J., Teixeira, B. C. A., Seitzinger, A., Jack, D., Sormani, M. P., Uitdehaag, B. M. J., Versteeg, A., Comi, G., Kappos, L., De Stefano, N., Barkhof, F.
Publicado 2023